187 related articles for article (PubMed ID: 31175371)
1. Metalloproteinases in nervous system function and pathology: introduction.
Rivera S
Cell Mol Life Sci; 2019 Aug; 76(16):3051-3053. PubMed ID: 31175371
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
3. The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ; Pagenstecher A; Campbell IL
J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
[TBL] [Abstract][Full Text] [Related]
4. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
[TBL] [Abstract][Full Text] [Related]
5. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in the CNS: interferons get nervous.
Chopra S; Overall CM; Dufour A
Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.
Gardner J; Ghorpade A
J Neurosci Res; 2003 Dec; 74(6):801-6. PubMed ID: 14648584
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases During Axonal Regeneration, a Multifactorial Role from Start to Finish.
Andries L; Van Hove I; Moons L; De Groef L
Mol Neurobiol; 2017 Apr; 54(3):2114-2125. PubMed ID: 26924318
[TBL] [Abstract][Full Text] [Related]
12. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
Nagase H; Brew K
Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
15. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
16. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
Mroczko B; Groblewska M; Barcikowska M
J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
[TBL] [Abstract][Full Text] [Related]
17. Multiple roles of metalloproteinases in neurological disorders.
Yang Y; Hill JW; Rosenberg GA
Prog Mol Biol Transl Sci; 2011; 99():241-63. PubMed ID: 21238938
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK; Waters JG; Kevorkian L; Darrah C; Cooper A; Donell ST; Clark IM
Arthritis Res Ther; 2006; 8(4):R124. PubMed ID: 16859525
[TBL] [Abstract][Full Text] [Related]
19. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
20. Metalloproteases and rotator cuff disease.
Del Buono A; Oliva F; Longo UG; Rodeo SA; Orchard J; Denaro V; Maffulli N
J Shoulder Elbow Surg; 2012 Feb; 21(2):200-8. PubMed ID: 22244063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]